nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—CCR1—respiratory system—obesity	0.0169	0.166	CbGeAlD
Raltegravir—CCR1—cardiovascular system—obesity	0.0129	0.127	CbGeAlD
Raltegravir—CCR1—pituitary gland—obesity	0.0115	0.112	CbGeAlD
Raltegravir—CCR1—adipose tissue—obesity	0.0114	0.112	CbGeAlD
Raltegravir—CCR1—digestive system—obesity	0.0107	0.105	CbGeAlD
Raltegravir—CCR1—adrenal gland—obesity	0.0102	0.1	CbGeAlD
Raltegravir—CCR1—endocrine gland—obesity	0.00888	0.0871	CbGeAlD
Raltegravir—CCR1—liver—obesity	0.00801	0.0785	CbGeAlD
Raltegravir—UGT1A1—digestive system—obesity	0.00442	0.0433	CbGeAlD
Raltegravir—UGT1A1—endocrine gland—obesity	0.00365	0.0358	CbGeAlD
Raltegravir—UGT1A1—liver—obesity	0.00329	0.0323	CbGeAlD
Raltegravir—Ill-defined disorder—Orlistat—obesity	0.000406	0.000792	CcSEcCtD
Raltegravir—Headache—Cimetidine—obesity	0.000405	0.000791	CcSEcCtD
Raltegravir—Nausea—Diethylpropion—obesity	0.000404	0.000788	CcSEcCtD
Raltegravir—Erythema multiforme—Bupropion—obesity	0.000401	0.000782	CcSEcCtD
Raltegravir—Lethargy—Topiramate—obesity	0.000399	0.000778	CcSEcCtD
Raltegravir—Tremor—Sibutramine—obesity	0.000397	0.000774	CcSEcCtD
Raltegravir—Eye disorder—Bupropion—obesity	0.000396	0.000773	CcSEcCtD
Raltegravir—Tinnitus—Bupropion—obesity	0.000395	0.000772	CcSEcCtD
Raltegravir—Malaise—Orlistat—obesity	0.000395	0.00077	CcSEcCtD
Raltegravir—Cardiac disorder—Bupropion—obesity	0.000394	0.000768	CcSEcCtD
Raltegravir—Vertigo—Orlistat—obesity	0.000393	0.000767	CcSEcCtD
Raltegravir—Ill-defined disorder—Sibutramine—obesity	0.000393	0.000767	CcSEcCtD
Raltegravir—Anaemia—Sibutramine—obesity	0.000391	0.000764	CcSEcCtD
Raltegravir—Pain in extremity—Topiramate—obesity	0.000391	0.000762	CcSEcCtD
Raltegravir—Agitation—Sibutramine—obesity	0.000389	0.000759	CcSEcCtD
Raltegravir—Palpitations—Orlistat—obesity	0.000387	0.000755	CcSEcCtD
Raltegravir—Angiopathy—Bupropion—obesity	0.000385	0.000751	CcSEcCtD
Raltegravir—Affect lability—Topiramate—obesity	0.000384	0.00075	CcSEcCtD
Raltegravir—Migraine—Topiramate—obesity	0.000384	0.00075	CcSEcCtD
Raltegravir—Nausea—Cimetidine—obesity	0.000384	0.00075	CcSEcCtD
Raltegravir—Immune system disorder—Bupropion—obesity	0.000383	0.000747	CcSEcCtD
Raltegravir—Mediastinal disorder—Bupropion—obesity	0.000382	0.000746	CcSEcCtD
Raltegravir—Malaise—Sibutramine—obesity	0.000382	0.000745	CcSEcCtD
Raltegravir—Cough—Orlistat—obesity	0.000382	0.000745	CcSEcCtD
Raltegravir—Psychotic disorder—Topiramate—obesity	0.000381	0.000744	CcSEcCtD
Raltegravir—Chills—Bupropion—obesity	0.000381	0.000743	CcSEcCtD
Raltegravir—Vertigo—Sibutramine—obesity	0.00038	0.000742	CcSEcCtD
Raltegravir—Face oedema—Topiramate—obesity	0.000377	0.000736	CcSEcCtD
Raltegravir—Alopecia—Bupropion—obesity	0.000375	0.000731	CcSEcCtD
Raltegravir—Palpitations—Sibutramine—obesity	0.000374	0.00073	CcSEcCtD
Raltegravir—Myalgia—Orlistat—obesity	0.000373	0.000727	CcSEcCtD
Raltegravir—Chest pain—Orlistat—obesity	0.000373	0.000727	CcSEcCtD
Raltegravir—Mental disorder—Bupropion—obesity	0.000372	0.000725	CcSEcCtD
Raltegravir—Anxiety—Orlistat—obesity	0.000371	0.000724	CcSEcCtD
Raltegravir—Mood swings—Topiramate—obesity	0.00037	0.000722	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00037	0.000722	CcSEcCtD
Raltegravir—Cough—Sibutramine—obesity	0.00037	0.000721	CcSEcCtD
Raltegravir—Malnutrition—Bupropion—obesity	0.000369	0.00072	CcSEcCtD
Raltegravir—Discomfort—Orlistat—obesity	0.000368	0.000718	CcSEcCtD
Raltegravir—Blood creatinine increased—Topiramate—obesity	0.000366	0.000714	CcSEcCtD
Raltegravir—Hypertension—Sibutramine—obesity	0.000366	0.000713	CcSEcCtD
Raltegravir—Dry mouth—Orlistat—obesity	0.000364	0.000711	CcSEcCtD
Raltegravir—Flatulence—Bupropion—obesity	0.000364	0.00071	CcSEcCtD
Raltegravir—Dysgeusia—Bupropion—obesity	0.000362	0.000705	CcSEcCtD
Raltegravir—Myalgia—Sibutramine—obesity	0.000361	0.000704	CcSEcCtD
Raltegravir—Arthralgia—Sibutramine—obesity	0.000361	0.000704	CcSEcCtD
Raltegravir—Chest pain—Sibutramine—obesity	0.000361	0.000704	CcSEcCtD
Raltegravir—Anxiety—Sibutramine—obesity	0.000359	0.000701	CcSEcCtD
Raltegravir—Nervousness—Bupropion—obesity	0.000359	0.0007	CcSEcCtD
Raltegravir—Back pain—Bupropion—obesity	0.000357	0.000697	CcSEcCtD
Raltegravir—Abdominal pain upper—Topiramate—obesity	0.000357	0.000696	CcSEcCtD
Raltegravir—Discomfort—Sibutramine—obesity	0.000356	0.000695	CcSEcCtD
Raltegravir—Infection—Orlistat—obesity	0.000355	0.000692	CcSEcCtD
Raltegravir—Breast disorder—Topiramate—obesity	0.000353	0.000689	CcSEcCtD
Raltegravir—Dry mouth—Sibutramine—obesity	0.000353	0.000688	CcSEcCtD
Raltegravir—Aspartate aminotransferase increased—Topiramate—obesity	0.000352	0.000686	CcSEcCtD
Raltegravir—Nervous system disorder—Orlistat—obesity	0.00035	0.000683	CcSEcCtD
Raltegravir—Nasopharyngitis—Topiramate—obesity	0.000349	0.000682	CcSEcCtD
Raltegravir—Confusional state—Sibutramine—obesity	0.000348	0.00068	CcSEcCtD
Raltegravir—Skin disorder—Orlistat—obesity	0.000347	0.000677	CcSEcCtD
Raltegravir—Tremor—Bupropion—obesity	0.000346	0.000675	CcSEcCtD
Raltegravir—Gastritis—Topiramate—obesity	0.000346	0.000674	CcSEcCtD
Raltegravir—Hyperhidrosis—Orlistat—obesity	0.000345	0.000674	CcSEcCtD
Raltegravir—Alanine aminotransferase increased—Topiramate—obesity	0.000344	0.000672	CcSEcCtD
Raltegravir—Infection—Sibutramine—obesity	0.000343	0.00067	CcSEcCtD
Raltegravir—Ill-defined disorder—Bupropion—obesity	0.000343	0.000668	CcSEcCtD
Raltegravir—Anaemia—Bupropion—obesity	0.000341	0.000666	CcSEcCtD
Raltegravir—Abdominal distension—Topiramate—obesity	0.00034	0.000663	CcSEcCtD
Raltegravir—Agitation—Bupropion—obesity	0.000339	0.000662	CcSEcCtD
Raltegravir—Thrombocytopenia—Sibutramine—obesity	0.000338	0.00066	CcSEcCtD
Raltegravir—Skin disorder—Sibutramine—obesity	0.000336	0.000655	CcSEcCtD
Raltegravir—Eosinophilia—Topiramate—obesity	0.000334	0.000652	CcSEcCtD
Raltegravir—Hyperhidrosis—Sibutramine—obesity	0.000334	0.000652	CcSEcCtD
Raltegravir—Malaise—Bupropion—obesity	0.000333	0.00065	CcSEcCtD
Raltegravir—Vertigo—Bupropion—obesity	0.000332	0.000647	CcSEcCtD
Raltegravir—Palpitations—Bupropion—obesity	0.000326	0.000637	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Orlistat—obesity	0.000325	0.000635	CcSEcCtD
Raltegravir—Bronchitis—Topiramate—obesity	0.000325	0.000633	CcSEcCtD
Raltegravir—Abdominal discomfort—Topiramate—obesity	0.000324	0.000631	CcSEcCtD
Raltegravir—Insomnia—Orlistat—obesity	0.000323	0.00063	CcSEcCtD
Raltegravir—Cough—Bupropion—obesity	0.000322	0.000629	CcSEcCtD
Raltegravir—Paraesthesia—Orlistat—obesity	0.000321	0.000626	CcSEcCtD
Raltegravir—Hypertension—Bupropion—obesity	0.000319	0.000622	CcSEcCtD
Raltegravir—Neutropenia—Topiramate—obesity	0.000316	0.000616	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Sibutramine—obesity	0.000315	0.000614	CcSEcCtD
Raltegravir—Dyspepsia—Orlistat—obesity	0.000314	0.000613	CcSEcCtD
Raltegravir—Myalgia—Bupropion—obesity	0.000314	0.000613	CcSEcCtD
Raltegravir—Arthralgia—Bupropion—obesity	0.000314	0.000613	CcSEcCtD
Raltegravir—Chest pain—Bupropion—obesity	0.000314	0.000613	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Topiramate—obesity	0.000314	0.000612	CcSEcCtD
Raltegravir—Anxiety—Bupropion—obesity	0.000313	0.000611	CcSEcCtD
Raltegravir—Insomnia—Sibutramine—obesity	0.000313	0.00061	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000312	0.000609	CcSEcCtD
Raltegravir—Erectile dysfunction—Topiramate—obesity	0.000311	0.000607	CcSEcCtD
Raltegravir—Discomfort—Bupropion—obesity	0.000311	0.000606	CcSEcCtD
Raltegravir—Decreased appetite—Orlistat—obesity	0.00031	0.000606	CcSEcCtD
Raltegravir—Paraesthesia—Sibutramine—obesity	0.00031	0.000606	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Orlistat—obesity	0.000308	0.000602	CcSEcCtD
Raltegravir—Fatigue—Orlistat—obesity	0.000308	0.000601	CcSEcCtD
Raltegravir—Dry mouth—Bupropion—obesity	0.000307	0.0006	CcSEcCtD
Raltegravir—Somnolence—Sibutramine—obesity	0.000307	0.0006	CcSEcCtD
Raltegravir—Weight increased—Topiramate—obesity	0.000307	0.000599	CcSEcCtD
Raltegravir—Weight decreased—Topiramate—obesity	0.000305	0.000596	CcSEcCtD
Raltegravir—Pain—Orlistat—obesity	0.000305	0.000596	CcSEcCtD
Raltegravir—Hyperglycaemia—Topiramate—obesity	0.000304	0.000594	CcSEcCtD
Raltegravir—Dyspepsia—Sibutramine—obesity	0.000304	0.000594	CcSEcCtD
Raltegravir—Confusional state—Bupropion—obesity	0.000304	0.000593	CcSEcCtD
Raltegravir—Infestation NOS—Topiramate—obesity	0.000301	0.000587	CcSEcCtD
Raltegravir—Infestation—Topiramate—obesity	0.000301	0.000587	CcSEcCtD
Raltegravir—Decreased appetite—Sibutramine—obesity	0.0003	0.000586	CcSEcCtD
Raltegravir—Depression—Topiramate—obesity	0.0003	0.000586	CcSEcCtD
Raltegravir—Infection—Bupropion—obesity	0.000299	0.000584	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Topiramate—obesity	0.000298	0.000582	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Sibutramine—obesity	0.000298	0.000582	CcSEcCtD
Raltegravir—Renal failure—Topiramate—obesity	0.000296	0.000577	CcSEcCtD
Raltegravir—Constipation—Sibutramine—obesity	0.000296	0.000577	CcSEcCtD
Raltegravir—Pain—Sibutramine—obesity	0.000296	0.000577	CcSEcCtD
Raltegravir—Nervous system disorder—Bupropion—obesity	0.000295	0.000577	CcSEcCtD
Raltegravir—Neuropathy peripheral—Topiramate—obesity	0.000295	0.000576	CcSEcCtD
Raltegravir—Thrombocytopenia—Bupropion—obesity	0.000295	0.000576	CcSEcCtD
Raltegravir—Feeling abnormal—Orlistat—obesity	0.000294	0.000574	CcSEcCtD
Raltegravir—Skin disorder—Bupropion—obesity	0.000293	0.000571	CcSEcCtD
Raltegravir—Gastrointestinal pain—Orlistat—obesity	0.000292	0.00057	CcSEcCtD
Raltegravir—Hyperhidrosis—Bupropion—obesity	0.000291	0.000568	CcSEcCtD
Raltegravir—Haematuria—Topiramate—obesity	0.000287	0.00056	CcSEcCtD
Raltegravir—Feeling abnormal—Sibutramine—obesity	0.000285	0.000556	CcSEcCtD
Raltegravir—Epistaxis—Topiramate—obesity	0.000284	0.000554	CcSEcCtD
Raltegravir—Urticaria—Orlistat—obesity	0.000284	0.000554	CcSEcCtD
Raltegravir—Gastrointestinal pain—Sibutramine—obesity	0.000283	0.000551	CcSEcCtD
Raltegravir—Body temperature increased—Orlistat—obesity	0.000282	0.000551	CcSEcCtD
Raltegravir—Abdominal pain—Orlistat—obesity	0.000282	0.000551	CcSEcCtD
Raltegravir—Urticaria—Sibutramine—obesity	0.000275	0.000536	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Bupropion—obesity	0.000275	0.000536	CcSEcCtD
Raltegravir—Abdominal pain—Sibutramine—obesity	0.000273	0.000533	CcSEcCtD
Raltegravir—Body temperature increased—Sibutramine—obesity	0.000273	0.000533	CcSEcCtD
Raltegravir—Insomnia—Bupropion—obesity	0.000273	0.000532	CcSEcCtD
Raltegravir—Paraesthesia—Bupropion—obesity	0.000271	0.000528	CcSEcCtD
Raltegravir—Hepatitis—Topiramate—obesity	0.00027	0.000527	CcSEcCtD
Raltegravir—Hallucination—Topiramate—obesity	0.000269	0.000525	CcSEcCtD
Raltegravir—Hypoaesthesia—Topiramate—obesity	0.000269	0.000525	CcSEcCtD
Raltegravir—Somnolence—Bupropion—obesity	0.000268	0.000523	CcSEcCtD
Raltegravir—Urinary tract disorder—Topiramate—obesity	0.000267	0.000521	CcSEcCtD
Raltegravir—Oedema peripheral—Topiramate—obesity	0.000266	0.000519	CcSEcCtD
Raltegravir—Connective tissue disorder—Topiramate—obesity	0.000266	0.000518	CcSEcCtD
Raltegravir—Dyspepsia—Bupropion—obesity	0.000265	0.000518	CcSEcCtD
Raltegravir—Urethral disorder—Topiramate—obesity	0.000265	0.000517	CcSEcCtD
Raltegravir—Hypersensitivity—Orlistat—obesity	0.000263	0.000513	CcSEcCtD
Raltegravir—Decreased appetite—Bupropion—obesity	0.000262	0.000511	CcSEcCtD
Raltegravir—Visual impairment—Topiramate—obesity	0.00026	0.000508	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Bupropion—obesity	0.00026	0.000508	CcSEcCtD
Raltegravir—Fatigue—Bupropion—obesity	0.00026	0.000507	CcSEcCtD
Raltegravir—Pain—Bupropion—obesity	0.000258	0.000503	CcSEcCtD
Raltegravir—Constipation—Bupropion—obesity	0.000258	0.000503	CcSEcCtD
Raltegravir—Asthenia—Orlistat—obesity	0.000256	0.0005	CcSEcCtD
Raltegravir—Erythema multiforme—Topiramate—obesity	0.000255	0.000499	CcSEcCtD
Raltegravir—Hypersensitivity—Sibutramine—obesity	0.000255	0.000497	CcSEcCtD
Raltegravir—Pruritus—Orlistat—obesity	0.000253	0.000493	CcSEcCtD
Raltegravir—Eye disorder—Topiramate—obesity	0.000252	0.000493	CcSEcCtD
Raltegravir—Tinnitus—Topiramate—obesity	0.000252	0.000492	CcSEcCtD
Raltegravir—Cardiac disorder—Topiramate—obesity	0.000251	0.000489	CcSEcCtD
Raltegravir—Feeling abnormal—Bupropion—obesity	0.000248	0.000485	CcSEcCtD
Raltegravir—Asthenia—Sibutramine—obesity	0.000248	0.000484	CcSEcCtD
Raltegravir—Gastrointestinal pain—Bupropion—obesity	0.000246	0.000481	CcSEcCtD
Raltegravir—Angiopathy—Topiramate—obesity	0.000245	0.000478	CcSEcCtD
Raltegravir—Pruritus—Sibutramine—obesity	0.000245	0.000477	CcSEcCtD
Raltegravir—Diarrhoea—Orlistat—obesity	0.000244	0.000477	CcSEcCtD
Raltegravir—Immune system disorder—Topiramate—obesity	0.000244	0.000476	CcSEcCtD
Raltegravir—Mediastinal disorder—Topiramate—obesity	0.000244	0.000475	CcSEcCtD
Raltegravir—Chills—Topiramate—obesity	0.000242	0.000473	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—ADRB2—obesity	0.000242	0.000627	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP2E1—obesity	0.000239	0.000621	CbGpPWpGaD
Raltegravir—Urticaria—Bupropion—obesity	0.000239	0.000467	CcSEcCtD
Raltegravir—Alopecia—Topiramate—obesity	0.000239	0.000466	CcSEcCtD
Raltegravir—Body temperature increased—Bupropion—obesity	0.000238	0.000465	CcSEcCtD
Raltegravir—Abdominal pain—Bupropion—obesity	0.000238	0.000465	CcSEcCtD
Raltegravir—Mental disorder—Topiramate—obesity	0.000237	0.000462	CcSEcCtD
Raltegravir—Diarrhoea—Sibutramine—obesity	0.000236	0.000461	CcSEcCtD
Raltegravir—Dizziness—Orlistat—obesity	0.000236	0.000461	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—CCL5—obesity	0.000236	0.000612	CbGpPWpGaD
Raltegravir—Erythema—Topiramate—obesity	0.000235	0.000459	CcSEcCtD
Raltegravir—Malnutrition—Topiramate—obesity	0.000235	0.000459	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCK—obesity	0.000234	0.000606	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PRKG1—obesity	0.000234	0.000606	CbGpPWpGaD
Raltegravir—Flatulence—Topiramate—obesity	0.000232	0.000452	CcSEcCtD
Raltegravir—Dysgeusia—Topiramate—obesity	0.00023	0.000449	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—GNB3—obesity	0.00023	0.000597	CbGpPWpGaD
Raltegravir—Dizziness—Sibutramine—obesity	0.000229	0.000446	CcSEcCtD
Raltegravir—Nervousness—Topiramate—obesity	0.000228	0.000446	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—RBP4—obesity	0.000228	0.000591	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GLP1R—obesity	0.000228	0.000591	CbGpPWpGaD
Raltegravir—Back pain—Topiramate—obesity	0.000228	0.000444	CcSEcCtD
Raltegravir—Vomiting—Orlistat—obesity	0.000227	0.000443	CcSEcCtD
Raltegravir—Rash—Orlistat—obesity	0.000225	0.000439	CcSEcCtD
Raltegravir—UGT1A1—NRF2 pathway—HMOX1—obesity	0.000225	0.000584	CbGpPWpGaD
Raltegravir—Dermatitis—Orlistat—obesity	0.000225	0.000439	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—GNAS—obesity	0.000224	0.000582	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HRH3—obesity	0.000224	0.000581	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCKAR—obesity	0.000224	0.000581	CbGpPWpGaD
Raltegravir—Headache—Orlistat—obesity	0.000224	0.000437	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—GGT1—obesity	0.000223	0.000578	CbGpPWpGaD
Raltegravir—Hypersensitivity—Bupropion—obesity	0.000222	0.000433	CcSEcCtD
Raltegravir—Tremor—Topiramate—obesity	0.00022	0.00043	CcSEcCtD
Raltegravir—Vomiting—Sibutramine—obesity	0.00022	0.000429	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—NCOA1—obesity	0.00022	0.000569	CbGpPWpGaD
Raltegravir—Ill-defined disorder—Topiramate—obesity	0.000218	0.000426	CcSEcCtD
Raltegravir—Rash—Sibutramine—obesity	0.000218	0.000425	CcSEcCtD
Raltegravir—Dermatitis—Sibutramine—obesity	0.000218	0.000425	CcSEcCtD
Raltegravir—Anaemia—Topiramate—obesity	0.000217	0.000424	CcSEcCtD
Raltegravir—Headache—Sibutramine—obesity	0.000217	0.000423	CcSEcCtD
Raltegravir—UGT1A1—Biological oxidations—CYP19A1—obesity	0.000216	0.000561	CbGpPWpGaD
Raltegravir—Asthenia—Bupropion—obesity	0.000216	0.000422	CcSEcCtD
Raltegravir—Agitation—Topiramate—obesity	0.000216	0.000422	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PRKAR2B—obesity	0.000216	0.000559	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—obesity	0.000215	0.000559	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL5—obesity	0.000214	0.000556	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP19A1—obesity	0.000213	0.000553	CbGpPWpGaD
Raltegravir—Pruritus—Bupropion—obesity	0.000213	0.000416	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—PRKCD—obesity	0.000213	0.000552	CbGpPWpGaD
Raltegravir—Nausea—Orlistat—obesity	0.000212	0.000414	CcSEcCtD
Raltegravir—Malaise—Topiramate—obesity	0.000212	0.000414	CcSEcCtD
Raltegravir—Vertigo—Topiramate—obesity	0.000211	0.000412	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NCF2—obesity	0.000208	0.00054	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—HTR2A—obesity	0.000208	0.00054	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—C3—obesity	0.000208	0.000539	CbGpPWpGaD
Raltegravir—Palpitations—Topiramate—obesity	0.000208	0.000406	CcSEcCtD
Raltegravir—Diarrhoea—Bupropion—obesity	0.000206	0.000402	CcSEcCtD
Raltegravir—Nausea—Sibutramine—obesity	0.000205	0.000401	CcSEcCtD
Raltegravir—Cough—Topiramate—obesity	0.000205	0.000401	CcSEcCtD
Raltegravir—Hypertension—Topiramate—obesity	0.000203	0.000396	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NPY—obesity	0.000203	0.000526	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CA3—obesity	0.000202	0.000525	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOC3—obesity	0.000202	0.000523	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IAPP—obesity	0.000202	0.000523	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—COMT—obesity	0.000201	0.000522	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—obesity	0.000201	0.000522	CbGpPWpGaD
Raltegravir—Arthralgia—Topiramate—obesity	0.0002	0.000391	CcSEcCtD
Raltegravir—Myalgia—Topiramate—obesity	0.0002	0.000391	CcSEcCtD
Raltegravir—Chest pain—Topiramate—obesity	0.0002	0.000391	CcSEcCtD
Raltegravir—Anxiety—Topiramate—obesity	0.0002	0.000389	CcSEcCtD
Raltegravir—Dizziness—Bupropion—obesity	0.000199	0.000389	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000199	0.000388	CcSEcCtD
Raltegravir—UGT1A1—Metapathway biotransformation—COMT—obesity	0.000198	0.000514	CbGpPWpGaD
Raltegravir—Discomfort—Topiramate—obesity	0.000198	0.000386	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—AGT—obesity	0.000198	0.000512	CbGpPWpGaD
Raltegravir—Dry mouth—Topiramate—obesity	0.000196	0.000382	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HTR1B—obesity	0.000196	0.000508	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CRH—obesity	0.000196	0.000508	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SDC1—obesity	0.000194	0.000502	CbGpPWpGaD
Raltegravir—Confusional state—Topiramate—obesity	0.000194	0.000378	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—PRKCD—obesity	0.000193	0.000501	CbGpPWpGaD
Raltegravir—Vomiting—Bupropion—obesity	0.000192	0.000374	CcSEcCtD
Raltegravir—Infection—Topiramate—obesity	0.000191	0.000372	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—AKR1C3—obesity	0.000191	0.000494	CbGpPWpGaD
Raltegravir—Rash—Bupropion—obesity	0.00019	0.000371	CcSEcCtD
Raltegravir—Dermatitis—Bupropion—obesity	0.00019	0.00037	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—HTR2A—obesity	0.000189	0.00049	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—C3—obesity	0.000189	0.00049	CbGpPWpGaD
Raltegravir—Headache—Bupropion—obesity	0.000189	0.000368	CcSEcCtD
Raltegravir—Nervous system disorder—Topiramate—obesity	0.000188	0.000367	CcSEcCtD
Raltegravir—Thrombocytopenia—Topiramate—obesity	0.000188	0.000367	CcSEcCtD
Raltegravir—Skin disorder—Topiramate—obesity	0.000186	0.000364	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NPS—obesity	0.000186	0.000481	CbGpPWpGaD
Raltegravir—Hyperhidrosis—Topiramate—obesity	0.000186	0.000362	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—PRKCB—obesity	0.000183	0.000473	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—F2—obesity	0.000183	0.000473	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DRD1—obesity	0.000182	0.000472	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HTR2C—obesity	0.000182	0.000472	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGT—obesity	0.000179	0.000465	CbGpPWpGaD
Raltegravir—Nausea—Bupropion—obesity	0.000179	0.000349	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NTRK2—obesity	0.000177	0.000459	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADRB1—obesity	0.000176	0.000457	CbGpPWpGaD
Raltegravir—Musculoskeletal discomfort—Topiramate—obesity	0.000175	0.000341	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—PIK3CG—obesity	0.000175	0.000453	CbGpPWpGaD
Raltegravir—Insomnia—Topiramate—obesity	0.000174	0.000339	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—GHRL—obesity	0.000173	0.000448	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PARP1—obesity	0.000173	0.000448	CbGpPWpGaD
Raltegravir—Paraesthesia—Topiramate—obesity	0.000172	0.000336	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—GLRX—obesity	0.000172	0.000446	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DRD4—obesity	0.000171	0.000444	CbGpPWpGaD
Raltegravir—Somnolence—Topiramate—obesity	0.000171	0.000333	CcSEcCtD
Raltegravir—Dyspepsia—Topiramate—obesity	0.000169	0.00033	CcSEcCtD
Raltegravir—Decreased appetite—Topiramate—obesity	0.000167	0.000326	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—POMC—obesity	0.000166	0.000431	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—F2—obesity	0.000166	0.00043	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PRKCB—obesity	0.000166	0.00043	CbGpPWpGaD
Raltegravir—Gastrointestinal disorder—Topiramate—obesity	0.000166	0.000323	CcSEcCtD
Raltegravir—Fatigue—Topiramate—obesity	0.000165	0.000323	CcSEcCtD
Raltegravir—Pain—Topiramate—obesity	0.000164	0.00032	CcSEcCtD
Raltegravir—Constipation—Topiramate—obesity	0.000164	0.00032	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CNR1—obesity	0.000163	0.000424	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TCF7L2—obesity	0.000161	0.000416	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AKT2—obesity	0.00016	0.000414	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—DRD2—obesity	0.000159	0.000414	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PIK3CG—obesity	0.000159	0.000411	CbGpPWpGaD
Raltegravir—Feeling abnormal—Topiramate—obesity	0.000158	0.000309	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—GCG—obesity	0.000158	0.000409	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTPN1—obesity	0.000158	0.000409	CbGpPWpGaD
Raltegravir—Gastrointestinal pain—Topiramate—obesity	0.000157	0.000306	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—PIK3CD—obesity	0.000154	0.000398	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—INSIG2—obesity	0.000153	0.000398	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPM1L—obesity	0.000153	0.000398	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ETFDH—obesity	0.000153	0.000398	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—OTC—obesity	0.000153	0.000398	CbGpPWpGaD
Raltegravir—Urticaria—Topiramate—obesity	0.000152	0.000298	CcSEcCtD
Raltegravir—Abdominal pain—Topiramate—obesity	0.000152	0.000296	CcSEcCtD
Raltegravir—Body temperature increased—Topiramate—obesity	0.000152	0.000296	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—POMC—obesity	0.000151	0.000392	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PRL—obesity	0.000151	0.000391	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—STK11—obesity	0.000148	0.000385	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCL2—obesity	0.000148	0.000383	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLG—obesity	0.000147	0.000381	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—RHOA—obesity	0.000147	0.00038	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AKT2—obesity	0.000145	0.000376	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PIK3R1—obesity	0.000145	0.000376	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—FOXO3—obesity	0.000143	0.000371	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADRB2—obesity	0.000143	0.00037	CbGpPWpGaD
Raltegravir—Hypersensitivity—Topiramate—obesity	0.000141	0.000276	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—SOCS1—obesity	0.000141	0.000365	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—INPP5E—obesity	0.00014	0.000364	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPT—obesity	0.00014	0.000364	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—UQCRC2—obesity	0.00014	0.000364	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PIK3CD—obesity	0.000139	0.000362	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SOCS3—obesity	0.000139	0.00036	CbGpPWpGaD
Raltegravir—Asthenia—Topiramate—obesity	0.000138	0.000269	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—GNB3—obesity	0.000136	0.000353	CbGpPWpGaD
Raltegravir—Pruritus—Topiramate—obesity	0.000136	0.000265	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—TYK2—obesity	0.000134	0.000348	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PIK3CB—obesity	0.000134	0.000347	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF2—obesity	0.000134	0.000347	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—RHOA—obesity	0.000133	0.000345	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GNAS—obesity	0.000132	0.000344	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PIK3R1—obesity	0.000132	0.000341	CbGpPWpGaD
Raltegravir—Diarrhoea—Topiramate—obesity	0.000131	0.000256	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ME1—obesity	0.00013	0.000338	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALDH6A1—obesity	0.00013	0.000338	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SUCLG2—obesity	0.00013	0.000338	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—POMC—obesity	0.00013	0.000337	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOB—obesity	0.00013	0.000336	CbGpPWpGaD
Raltegravir—Dizziness—Topiramate—obesity	0.000127	0.000248	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCL5—obesity	0.000127	0.000329	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LPL—obesity	0.000124	0.000321	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—FOXO1—obesity	0.000123	0.000319	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—RPS6KB1—obesity	0.000123	0.000318	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PNPLA3—obesity	0.000123	0.000318	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—UCP1—obesity	0.000123	0.000318	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—COX7C—obesity	0.000123	0.000318	CbGpPWpGaD
Raltegravir—Vomiting—Topiramate—obesity	0.000122	0.000238	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—PIK3CB—obesity	0.000122	0.000315	CbGpPWpGaD
Raltegravir—Rash—Topiramate—obesity	0.000121	0.000236	CcSEcCtD
Raltegravir—Dermatitis—Topiramate—obesity	0.000121	0.000236	CcSEcCtD
Raltegravir—Headache—Topiramate—obesity	0.00012	0.000235	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—DGAT2—obesity	0.000116	0.000302	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CS—obesity	0.000116	0.000302	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SUCLA2—obesity	0.000116	0.000302	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CPS1—obesity	0.000116	0.000302	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PRKCD—obesity	0.000114	0.000296	CbGpPWpGaD
Raltegravir—Nausea—Topiramate—obesity	0.000114	0.000223	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HTR2A—obesity	0.000112	0.00029	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—C3—obesity	0.000112	0.000289	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LIPE—obesity	0.000111	0.000288	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MUT—obesity	0.000111	0.000288	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYB5A—obesity	0.000106	0.000276	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—DGAT1—obesity	0.000106	0.000276	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IRS2—obesity	0.000106	0.000275	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGT—obesity	0.000106	0.000275	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LEP—obesity	0.000104	0.000269	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOE—obesity	0.000104	0.000269	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CAV1—obesity	0.000103	0.000267	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—APOA1—obesity	0.000103	0.000266	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ACLY—obesity	0.000102	0.000265	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ESR1—obesity	9.91e-05	0.000257	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALOX12—obesity	9.89e-05	0.000256	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ENPP1—obesity	9.89e-05	0.000256	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—F2—obesity	9.79e-05	0.000254	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PRKCB—obesity	9.79e-05	0.000254	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—BAD—obesity	9.68e-05	0.000251	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMGCS1—obesity	9.57e-05	0.000248	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PIK3CG—obesity	9.37e-05	0.000243	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PLIN1—obesity	9.29e-05	0.000241	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ACADM—obesity	9.29e-05	0.000241	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SAT1—obesity	9.29e-05	0.000241	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PNPLA2—obesity	9.29e-05	0.000241	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ANGPTL4—obesity	9.29e-05	0.000241	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PFKFB3—obesity	9.29e-05	0.000241	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IRS1—obesity	9.26e-05	0.00024	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ACACB—obesity	9.04e-05	0.000234	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYTB—obesity	9.04e-05	0.000234	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—OXCT1—obesity	9.04e-05	0.000234	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—POMC—obesity	8.92e-05	0.000231	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—INS—obesity	8.87e-05	0.00023	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PNLIP—obesity	8.81e-05	0.000228	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SRD5A1—obesity	8.81e-05	0.000228	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL2—obesity	8.73e-05	0.000226	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SDC3—obesity	8.6e-05	0.000223	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF1—obesity	8.58e-05	0.000223	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AKT2—obesity	8.57e-05	0.000222	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TGFB1—obesity	8.55e-05	0.000222	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—STS—obesity	8.41e-05	0.000218	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP26B1—obesity	8.41e-05	0.000218	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HK2—obesity	8.41e-05	0.000218	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PIK3CD—obesity	8.24e-05	0.000214	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARD—obesity	8.23e-05	0.000213	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PIK3CA—obesity	8.16e-05	0.000212	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SERPINE1—obesity	8.15e-05	0.000211	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC27A1—obesity	8.06e-05	0.000209	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TYK2—obesity	7.92e-05	0.000206	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—FABP4—obesity	7.9e-05	0.000205	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GLUL—obesity	7.9e-05	0.000205	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—RHOA—obesity	7.86e-05	0.000204	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PIK3R1—obesity	7.78e-05	0.000202	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NOS3—obesity	7.78e-05	0.000202	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—UCP2—obesity	7.49e-05	0.000194	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ECHS1—obesity	7.49e-05	0.000194	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HSD11B1—obesity	7.49e-05	0.000194	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—UCP3—obesity	7.49e-05	0.000194	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PIK3CA—obesity	7.41e-05	0.000192	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ADH1B—obesity	7.37e-05	0.000191	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARGC1B—obesity	7.26e-05	0.000188	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ACSL1—obesity	7.26e-05	0.000188	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPAM—obesity	7.26e-05	0.000188	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PIK3CB—obesity	7.18e-05	0.000186	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MTOR—obesity	7.18e-05	0.000186	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HADH—obesity	7.04e-05	0.000183	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PCK1—obesity	7.04e-05	0.000183	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—FADS1—obesity	7.04e-05	0.000183	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ACP5—obesity	6.85e-05	0.000178	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—G6PD—obesity	6.68e-05	0.000173	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AKT1—obesity	6.67e-05	0.000173	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HK1—obesity	6.6e-05	0.000171	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SREBF2—obesity	6.6e-05	0.000171	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6—obesity	6.56e-05	0.00017	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPA—obesity	6.37e-05	0.000165	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MMP9—obesity	6.24e-05	0.000162	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPIN1—obesity	6.23e-05	0.000162	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA5—obesity	6.11e-05	0.000158	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MAPK8—obesity	6.07e-05	0.000157	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AKT1—obesity	6.05e-05	0.000157	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC22A1—obesity	5.83e-05	0.000151	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CLOCK—obesity	5.83e-05	0.000151	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SULT2A1—obesity	5.68e-05	0.000147	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GLP1R—obesity	5.68e-05	0.000147	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—DPYD—obesity	5.59e-05	0.000145	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—STAT3—obesity	5.55e-05	0.000144	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PRKAR2B—obesity	5.38e-05	0.000139	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—DCN—obesity	5.34e-05	0.000138	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CPT1A—obesity	5.19e-05	0.000135	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MYC—obesity	5.16e-05	0.000134	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TGFB1—obesity	5.14e-05	0.000133	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NAMPT—obesity	5.09e-05	0.000132	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LIPC—obesity	5.06e-05	0.000131	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCK—obesity	5.06e-05	0.000131	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOC3—obesity	5.03e-05	0.00013	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CETP—obesity	4.88e-05	0.000127	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SDC1—obesity	4.83e-05	0.000125	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AKR1C3—obesity	4.75e-05	0.000123	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SCARB1—obesity	4.68e-05	0.000121	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SREBF1—obesity	4.54e-05	0.000118	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT2—obesity	4.42e-05	0.000115	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PIK3CA—obesity	4.38e-05	0.000114	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—FASN—obesity	4.32e-05	0.000112	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—BCHE—obesity	4.3e-05	0.000112	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP2E1—obesity	4.15e-05	0.000108	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NQO1—obesity	4.1e-05	0.000106	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCG—obesity	3.94e-05	0.000102	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC2A4—obesity	3.94e-05	0.000102	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYCS—obesity	3.88e-05	0.000101	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6—obesity	3.88e-05	0.000101	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GGT1—obesity	3.81e-05	9.88e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GOT1—obesity	3.81e-05	9.88e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NCOA1—obesity	3.75e-05	9.74e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—STK11—obesity	3.7e-05	9.6e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP19A1—obesity	3.7e-05	9.6e-05	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AKT1—obesity	3.58e-05	9.27e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—COMT—obesity	3.44e-05	8.92e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GNB3—obesity	3.39e-05	8.8e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARGC1A—obesity	3.39e-05	8.8e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMOX1—obesity	3.38e-05	8.76e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GNAS—obesity	3.3e-05	8.56e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOB—obesity	3.23e-05	8.39e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPL—obesity	3.09e-05	8.01e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPX1—obesity	3.01e-05	7.81e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CD36—obesity	2.93e-05	7.61e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MTHFR—obesity	2.78e-05	7.21e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARA—obesity	2.73e-05	7.07e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AGT—obesity	2.64e-05	6.85e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOE—obesity	2.59e-05	6.71e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CAV1—obesity	2.56e-05	6.65e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA1—obesity	2.56e-05	6.64e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3CG—obesity	2.34e-05	6.06e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARG—obesity	2.25e-05	5.85e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—POMC—obesity	2.22e-05	5.77e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—INS—obesity	2.21e-05	5.73e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3CD—obesity	2.05e-05	5.33e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—obesity	2.03e-05	5.26e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NOS3—obesity	1.94e-05	5.03e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3R1—obesity	1.94e-05	5.03e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3CB—obesity	1.79e-05	4.64e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTGS2—obesity	1.77e-05	4.6e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3CA—obesity	1.09e-05	2.83e-05	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AKT1—obesity	8.91e-06	2.31e-05	CbGpPWpGaD
